Back to results
US 2022/0024939 A1Published application
Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones
AssigneeRecurium IP Holdings, LLC
InventorsPeter Qinhua Huang, Kevin Duane Bunker, Brant Clayton Boren, Sayee Gajanan Hegde, Hui Liu, Aditya Krishnan Unni, Sunny Abraham, Chad Daniel Hopkins, Sunil Paliwal
Life of this patent
Estimating the term…
Abstract
Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.
Claims5
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, having the structure:
- wherein:
- R1 is selected from the group consisting of hydrogen, halogen and a substituted or unsubstituted C1-C6 alkyl;
- Ring A is selected from the group consisting of a substituted or unsubstituted phenyl and a substituted or unsubstituted 5-6 membered monocyclic heteroaryl;
- Ring B is selected from the group consisting of a substituted or unsubstituted monocyclic 5-7 membered carbocyclyl and a substituted or unsubstituted 5-7 membered monocyclic heterocyclyl;
- R2 is selected from the group consisting of
- m is 0, 1, 2 or 3;
- R3 is selected from the group consisting of halogen and a substituted or unsubstituted C1-C6 alkyl;
- X is selected from the group consisting of hydrogen, halogen, hydroxy, cyano, a substituted or unsubstituted 4-6 membered monocyclic heterocyclyl, a substituted or unsubstituted amine(C1-C6 alkyl), a substituted or unsubstituted —NH—(CH2)1-6-amine, a mono-substituted amine, a di-substituted amine, an amino, a substituted or unsubstituted C1-C6 alkyl, a substituted or unsubstituted C1-C6 alkoxy, a substituted or unsubstituted C3-C6 cycloalkoxy, a substituted or unsubstituted (C1-C6 alkyl)acyl, a substituted or unsubstituted C-amido, a substituted or unsubstituted N-amido, a substituted or unsubstituted C-carboxy, a substituted or unsubstituted O-carboxy, a substituted or unsubstituted O-carbamyl and a substituted or unsubstituted N-carbamyl;
- Y is CH or N;
- Y1 is CR4A or N;
- Y2 is CR4B or N;
- Ring C is selected from the group consisting of a substituted or unsubstituted C6-C10 aryl, a substituted or unsubstituted monocyclic 5-10 membered heteroaryl, a substituted or unsubstituted monocyclic 5-7 membered carbocyclyl, a substituted or unsubstituted 5-7 membered monocyclic heterocyclyl and a substituted or unsubstituted 7-10 membered bicyclic heterocyclyl;
- R4A and R4B are independently selected from the group consisting of hydrogen, halogen and an unsubstituted C1-4 alkyl;
- and
- R5 is a substituted or unsubstituted 5-7 membered monocyclic heterocyclyl.
12 more elements
Dependencies are inferred from the claim text.